新疆医科大学学报2024,Vol.47Issue(4) :548-552,558.DOI:10.3969/j.issn.1009-5551.2024.04.016

脊髓电刺激治疗带状疱疹后神经痛患者血清β-EP、NT水平变化及对治疗反应性的评估价值

Changes of serum β-endorphin(β-EP)and neurotensin(NT)levels in patients with postherpetic neuralgia(PHN)treated with spinal cord electrical stimulation and evaluation value of therapeutic responsiveness

程瑾霞 张锐 程伟宁 黄荣 谭登云
新疆医科大学学报2024,Vol.47Issue(4) :548-552,558.DOI:10.3969/j.issn.1009-5551.2024.04.016

脊髓电刺激治疗带状疱疹后神经痛患者血清β-EP、NT水平变化及对治疗反应性的评估价值

Changes of serum β-endorphin(β-EP)and neurotensin(NT)levels in patients with postherpetic neuralgia(PHN)treated with spinal cord electrical stimulation and evaluation value of therapeutic responsiveness

程瑾霞 1张锐 1程伟宁 1黄荣 1谭登云1
扫码查看

作者信息

  • 1. 武汉市新洲区人民医院神经内科,武汉 431400
  • 折叠

摘要

目的 探讨脊髓电刺激(Spinal cord stimulation,SCS)治疗带状疱疹后神经痛(Postherpetic neuralgia,PHN)患者血清β-内啡肽(β-endorplhin,β-EP)、神经降压素(Neurotensin,NT)水平变化及对治疗反应性的评估价值.方法 选取2021年7月-2023年3月武汉市新洲区人民医院接受SCS治疗的PHN患者108例作为研究组,根据治疗6个月效果分为反应良好患者、反应差患者.根据随机病例对照研究原则1∶1选取同期常规药物治疗的PHN患者108例作为对照组.检测并比较两组血清β-EP、NT水平及对治疗反应性的评估价值.结果 治疗前,两组血清β-EP、NT水平比较,差异无统计学意义(P>0.05);治疗后,两组血清β-EP、NT水平较治疗前均升高,且研究组高于对照组(P<0.05).皮疹面积≥10 cm2、初治时间>3 d是PHN治疗反应差的独立危险因素,血清β-EP、NT水平升高是PHN治疗反应差的独立保护因素(P<0.05).受试者工作特征(Receiver operating characteristic curve,ROC)分析显示,血清 β-EP、NT 水平单独预测PHN治疗反应差的曲线下面积(Area under curve,AUC)值分别为0.776、0.793,加入多因素 Logistic回归模型后可将AUC值提升至0.936,高于血清β-EP(Z=3.490,P=0.001)、NT(Z=3.430,P=0.001)单独预测.结论 SCS治疗可提升PHN患者血清β-EP、NT水平,二者联合检测可为临床评估SCS疗效提供参考.

Abstract

Objective To investigate the changes of serum β-endorphin(β-EP)and neurotensin(NT)levels in patients with postherpetic neuralgia(PHN)and evaluate the therapeutic responsiveness.Methods A total of 108 PHN patients who received SCS treatment in thehospital from July 2021 to March 2023 were selected as the study group.The patients were further divided into well-responding patients and poorly-re-sponding patients based on their treatment outcomes after 6 months.Additionally,following the principle of 1∶1 random case-control study,108 PHN patients who underwent conventional drug treatment during the same period were selected as control group.The serum levels of β-EP and NT were measured and com-pared in each group.Results Before the treatment,the serum levels of β-EP and NT in the 2 groups were not significantly different(P>0.05),but after the treatment,the serum levels of β-EP and NT in the study group were significantly higher than those in the control group(P<0.05).Skin rash area ≥10 cm2 and initial treatment time>3d were independent risk factors for poor PHN response of SCS,and itelevated serum levels of β-EP and NT were independent protective factors for poor PHN response of SCS(P<0.05).ROC analysis showed that the AUC value of serum-βEP and NT levels alone in predicting the poor PHN response of SCS treatment was 0.776 and 0.793,respectively,and the AUC value was increased to 0.936 after the addition of multivariate Logistic regression model,which was higher than that of serum β-EP(Z=3.490,P=0.001)and NT(Z=3.430,P=0.001)levels predicted separately.Conclusion Serumβ-EP and NT levels in PHN patients are different before and after SCS treatment,and the serum β-EP and NT levels after the treatment are related to the long-term efficacy of SCS,and the combined detection can provide a reference for clinical evaluation of the long-term efficacy of SCS.

关键词

带状疱疹后神经痛/脊髓电刺激/β-内啡肽/神经降压素

Key words

postherpetic neuralgia/spinal cord electrical stimulation/beta-endorphins/neurotensin

引用本文复制引用

基金项目

湖北省卫生健康委科研项目(WJ2019M035)

出版年

2024
新疆医科大学学报
新疆医科大学

新疆医科大学学报

CSTPCD
影响因子:0.76
ISSN:1009-5551
参考文献量25
段落导航相关论文